FUROSCIX, a subcutaneous formulation of furosemide, can help overcome challenges in treating fluid overload:
Learn more about FUROSCIX efficacy
*
Based on mean ± SD 30-minute plasma concentration of 600 (± 209) ng/mL.1
SD=standard deviation.
or lying down
mostly in the lower extremities and abdomen
FUROSCIX is indicated for the treatment of edema (i.e., congestion, fluid overload, or hypervolemia) in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.
FUROSCIX is not for chronic use and should be replaced with oral diuretics as soon as practical.
Encourage your patients to recognize and report symptoms of fluid overload as soon as they present. This allows you the opportunity to offer them earlier at-home symptom relief.
Learn more about FUROSCIX use